Figure 2.
Monotherapy with onalespib or 177Lu-DOTATATE in spheroids. Growth of spheroids treated with (A, D and G) onalespib or (B, E and H) 177Lu-DOTATATE at day 14 (NCI-H460 cells) or day 20 (BON and NCI-H727 cells) with representative spheroid images (C, F and I) for the (A-C) BON, (D-F) NCI-H727 and (G-I) NCI-H460 cell-derived spheroids. Spheroids were treated with a daily concentration indicated in the graphs. Graphs display size normalized to the untreated cells (means ± standard deviation, n≥4); scale bar, 500 µm. 177Lu-DOT, 177Lu-DOTATATE. ****P≤0.0001; n.s., not significant.
